Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Home
Investire
ETFs
U.S.A.
AMEX
Robo Global Healthcare Technology and Innovation ETF (HTEC)
Robo Global Healthcare Technology and Innovation ETF (HTEC) Notizie

Robo Global Healthcare Technology and Innovation ETF (HTEC)

35,1266

0,00

(0,00%)

Chiuso 24 Giugno 10:00PM

0,00

0,00

(0,00%)

Dopo le ore di negoziazione: -

Discussioni in tempo reale e idee di trading: Fai trading con fiducia con la nostra potente piattaforma.

Premium

Hydron Technologies, Inc. and Brand Builders International, LLC Join Forces to Form New Entity

DELRAY BEACH, Fla., Nov. 11 /PRNewswire-FirstCall/ -- Hydron Technologies, Inc. (OTC:HTEC) (BULLETIN BOARD: HTEC) announced today that it has...

Hydron Technologies Awarded U.S. Patent for Self-Adjusting Cosmeceutical Delivery System

ST. PETERSBURG, Fla., Jan 18 /PRNewswire-FirstCall/ -- Hydron Technologies, Inc. (OTC:HTEC) (BULLETIN BOARD: HTEC) announced that it was...

Hydron Technologies, Inc. Reports Fourth Quarter Results

Hydron Technologies, Inc. Reports Fourth Quarter Results POMPANO BEACH, Fla., April 14 /PRNewswire-FirstCall/ -- Hydron Technologies, Inc...

Hydron Technologies, Inc. Adds Clinical and Regulatory Consultants, Plans to Seek FDA Approval for Wound Care Oxygenation Techno

Hydron Technologies, Inc. Adds Clinical and Regulatory Consultants, Plans to Seek FDA Approval for Wound Care Oxygenation Technology POMPANO...

Hydron Technologies, Inc. Receives Formal US Patent Approval for its Method of Tissue Oxygenation

Hydron Technologies, Inc. Receives Formal US Patent Approval for its Method of Tissue Oxygenation POMPANO BEACH, Fla., Dec. 11...

FAU and Hydron Release Wound Healing Cell Study Results

FAU and Hydron Release Wound Healing Cell Study Results POMPANO BEACH, Fla., Nov. 21 /PRNewswire-FirstCall/ -- Scientists at Florida Atlantic...

Hydron Technologies, Inc. Reports Third Quarter Results and Announces Completion of Private Placement Financing

Hydron Technologies, Inc. Reports Third Quarter Results and Announces Completion of Private Placement Financing POMPANO BEACH, Fla., Nov. 13...

US Market News

US Market News 3 minuti fa

Forrester: Nine In 10 US Marketing Agencies Use AI To Cut Costs At The Expense Of CreativityJune 24, 2026 3:00 AM
Business Wire New research calls on agencies and CMOs to shift their focus from AI-driven cost savings to preserving creativity and differentiation

US Market News

US Market News 3 minuti fa

Takeda Announces New Assignments of Directors and Appointment of Julie Kim as Representative Director, President and CEOJune 24, 2026 3:05 AM
Business Wire Board of Directors appoints Julie Kim as Representative Director, President & CEO following share

US Market News

US Market News 18 minuti fa

Signatera™ Receives Regulatory Approval in Japan for Colorectal CancerJune 24, 2026 3:00 AM
Business Wire First PMDA-approved molecular residual disease (MRD) test in Japan, supporting the use of Signatera in the adjuvant setting Commer

timberwolf7

timberwolf7 23 minuti fa

If you want the cheapest shares you can get? One would think
that would entail being patient for it to confirm a BOTTOM is in before
buying shares (aka, the 'cheapest' you would be able to get em).

I have no idea where this is going to stop sliding at. Just playing t

MightyX

MightyX 24 minuti fa

Likely strategic move to avoid OTC

MightyX

MightyX 24 minuti fa

Notice how they’re going from NASDAQ to NYSE

dinogreeves

dinogreeves 25 minuti fa

I am betting on 3 team parlay, Jason Kalisman, Atlanta Braves and New York Yankees, although I don't know much about baseball, but I do have my favorite, Anaheim Angels. Welp, off to bed, going to have great night sleep after listening to "I found my love in Portofino" by Andrea Bocelli.

PC retired

PC retired 26 minuti fa

Thank you, Mr Bystander. I would reckon this is only the start of the infighting and many similar cases are in the pipeline.

watcher777

watcher777 29 minuti fa

Has anyone ever Googled the address and looked on maps where the LLCs that bought professor Li's shares is located? It's a shack in Florida. I'm so glad I woke up. 😆
2804 Dawley Ave, Orlando, FL 32806

Plato_

Plato_ 29 minuti fa

Have one on the House! 🍻HEAR, HEAR. VeeMo $ t

US Market News

US Market News 33 minuti fa

MSCI Acquires First Street to Enhance Physical Climate Risk Capabilities for Financial Decision MakingJune 24, 2026 2:33 AM
Business Wire MSCI Inc. (NYSE: MSCI) is enhancing its global physical climate risk capabilities with the acquisition of First Street, a leading provider o

watcher777

watcher777 33 minuti fa

He has/had every right to be. However, I hope he can let this go and move on. These people are not worth the sweat off his sack.

vinmantoo

vinmantoo 33 minuti fa

I would have loved a deal already, especially one that would have avoided a raise at 10 dollars. That said right now the type of deal you might pursue very well may depend on a few factors that are around the corner. The two lawsuits, and the first clinical readout in immunology. That might give you

Mdk1

Mdk1 35 minuti fa

The importance of critical minerals ! Mrima Hill rare earth and niobium deposit ...
>>> "Every major power understands that whoever controls the supply chains controls the future."
https://www.armstrongeconomics.com/international-news/africa/us-strikes-deal-for-kenyas-rare-earth-miner

watcher777

watcher777 36 minuti fa

I'm leaning towards not. I was invested in this thing for a long time. I've been to the shareholder meetings, spoke with the executives, shook professor Li's hand, had breakfast with Tony and I'm convinced there is a very slight chance this company will ever be profitable. The technology is amazing!

Genz2

Genz2 37 minuti fa

Is Elon Musk like Henry Ford? Does he want to be like Henry Ford??

sentiment_stocks

sentiment_stocks 40 minuti fa

If MHRA did find the application was bogus… as you suggest… then they are corrupt, or just idiots.

vinmantoo

vinmantoo 42 minuti fa

Echoes of EDP-235.

As Dew said, Zeli isn't close to what happened with EDP-235 as Zeli not only completed phase 2 with stellar results for high risk but has been given the go ahead given for phase 3.EDP-235 only had early stage trial data.. Add in that Paxlovid was already on the mark

InvestorinAZ

InvestorinAZ 44 minuti fa

Clicked on your link and it says
"No results found for the past 5 years. Consider expanding the filed date range!"
Send a new link please. Not sure what you're looking at.

In all my conversations with the folks at VP, they've all said that they're not allowed to sell s

CA Market News

CA Market News 48 minuti fa

District Commences Drilling at the Österkälen Mineral License within the Alum Shale Properties in SwedenJune 24, 2026 2:00 AM
NewsfileV

US Market News

US Market News 48 minuti fa

Creating Shareholder Value Through a Possible SEGRO and Prologis CombinationJune 24, 2026 2:27 AM
PR Newswire (US) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO

snoopycomic

snoopycomic 48 minuti fa

Just give me $1.50

Just give me $1.50 1 ora fa

NEW!!! -- ELITE PREPARING FOR NASDAQ LISTING

1. This is the first time in the HISTORY of Elite where they have now REMOVED any mention of third-party pharmaceutical organizations in the "About" section of Elite's press releases.

2. Elite has also REWORDED the "About"

theorysuit

theorysuit 1 ora fa

And nwbo leadership is what fantastic. Lmfao. Can't even get a single approval in a sht small market let alone submit said reimbursement in said small market in nearly 3 years since they stumbled through submission and 6 years since data lock......fantastic nwbo leadership.. quite the accomplis

Robo Global Healthcare T...

Brandes Global Equity Fu...

Ramsay Generale De Sante

Tradr 2X Long ACHR Daily...

AXA Rosenberg Management...

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN

Hai già un account? Accedi

Non hai un account? Registrati

Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.